NO20033797L - Metode og formel for anti-tumor og anti-metastatisk virkning - Google Patents

Metode og formel for anti-tumor og anti-metastatisk virkning

Info

Publication number
NO20033797L
NO20033797L NO20033797A NO20033797A NO20033797L NO 20033797 L NO20033797 L NO 20033797L NO 20033797 A NO20033797 A NO 20033797A NO 20033797 A NO20033797 A NO 20033797A NO 20033797 L NO20033797 L NO 20033797L
Authority
NO
Norway
Prior art keywords
tumor
formula
metastatic effect
metastatic
effect
Prior art date
Application number
NO20033797A
Other languages
English (en)
Other versions
NO20033797D0 (no
Inventor
Brian C Giles
Original Assignee
Brian C Giles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brian C Giles filed Critical Brian C Giles
Publication of NO20033797D0 publication Critical patent/NO20033797D0/no
Publication of NO20033797L publication Critical patent/NO20033797L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20033797A 2001-02-28 2003-08-26 Metode og formel for anti-tumor og anti-metastatisk virkning NO20033797L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/006672 WO2002069955A1 (en) 2001-02-28 2001-02-28 Method and formula for anti-tumor and anti-matastatic effect

Publications (2)

Publication Number Publication Date
NO20033797D0 NO20033797D0 (no) 2003-08-26
NO20033797L true NO20033797L (no) 2003-10-28

Family

ID=21742372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033797A NO20033797L (no) 2001-02-28 2003-08-26 Metode og formel for anti-tumor og anti-metastatisk virkning

Country Status (8)

Country Link
US (1) US20050260277A1 (no)
EP (1) EP1372631A4 (no)
JP (1) JP2004530659A (no)
CN (1) CN1492758A (no)
CA (1) CA2442396A1 (no)
MX (1) MXPA03007783A (no)
NO (1) NO20033797L (no)
WO (1) WO2002069955A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002085297A2 (en) 2001-04-24 2002-10-31 East Carolina University Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
US7405207B2 (en) 2002-06-17 2008-07-29 Epigenesis Pharmaceuticals, Inc. Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
AT412447B (de) * 2002-11-27 2005-03-25 C Y L Handelsges M B H Mittel mit zerstörender wirkung auf maligne tumore sowie verfahren zu seiner herstellung
PL2256106T3 (pl) 2003-07-22 2015-08-31 Astex Therapeutics Ltd Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3)
WO2005065695A1 (en) * 2003-12-26 2005-07-21 Giles Brian C Method and formula for suppression of cancer, metastasis, vascularization, and pain suppression
AU2005281393B2 (en) * 2004-09-09 2012-01-12 Virbac (Australia) Pty Ltd Trace elements
US20070009612A1 (en) * 2004-12-16 2007-01-11 Barefoot Robert R Method for administering a composition to an animal
MX2007008809A (es) * 2005-01-21 2007-09-07 Astex Therapeutics Ltd Combinaciones de inhibidores de pirazol cinasa y otros agentes antitumor.
US8404718B2 (en) 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors
AR054425A1 (es) 2005-01-21 2007-06-27 Astex Therapeutics Ltd Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
WO2006081327A2 (en) * 2005-01-25 2006-08-03 University Of Vermont And State Agricultural College Small molecules that reduce fungal growth
CN100418540C (zh) * 2006-07-21 2008-09-17 黎约翰仲曾 具有止痛作用的药物组合物、贴剂及软膏剂
CN101214234B (zh) * 2008-01-10 2010-09-08 中国人民解放军第二军医大学 α-羟基酸在制备癌瘤体内注射治疗药物中的应用
WO2010011927A1 (en) 2008-07-25 2010-01-28 Noventis, Inc. Compositions and methods for the prevention and treatment of cardiovascular diseases
EP2371372A1 (en) * 2010-04-01 2011-10-05 Anrold Forbes Methods of promoting appetite suppression using alkali metals
CN108420827A (zh) 2010-07-22 2018-08-21 雷文制药有限公司 包含磁偶极子稳定化溶液的组合物及其用途
US10004762B2 (en) 2013-05-08 2018-06-26 Gambro Lundia Ab Dialysis formulation
KR101683635B1 (ko) 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물
CA2978680A1 (en) 2015-03-04 2016-09-09 Arnold Forbes Compositions and methods for treating drug addiction
AU2016294526A1 (en) * 2015-07-14 2018-02-08 Atossa Genetics Inc. Transpapillary methods and compositions for treating breast disorders
CN110317230B (zh) * 2018-03-30 2023-11-07 上海昇悦医药科技有限公司 磷酸盐类衍生物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7350500A (en) * 1999-08-31 2001-03-26 Brian C. Giles Method and formula for tumor remission and suppression of cancer

Also Published As

Publication number Publication date
EP1372631A4 (en) 2005-07-27
NO20033797D0 (no) 2003-08-26
EP1372631A1 (en) 2004-01-02
CA2442396A1 (en) 2002-09-12
US20050260277A1 (en) 2005-11-24
JP2004530659A (ja) 2004-10-07
MXPA03007783A (es) 2005-08-16
CN1492758A (zh) 2004-04-28
WO2002069955A1 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
NO20033797L (no) Metode og formel for anti-tumor og anti-metastatisk virkning
BRPI0313238A2 (pt) método
NO20044148L (no) Sammensetning og fremgangsmate for bronnrensing
NO20015547D0 (no) Halvsyntetisk fremgangsmåte og nye forbindelser
NO20041113L (no) Styrbar underrommings bunnhullsenhet og fremgangsmate
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
DK1664746T3 (da) Antioxidantsensor og fremgangsmåde
DE60205413D1 (de) Herstellungsverfahren
NO20021929L (no) Fremgangsmåte og anordning for brönnkomplettering
DE60319273D1 (de) Entzunderungsdüse
DE60327287D1 (de) Aufzeichnungsgerät
NO20054095D0 (no) Pyridyloksymetyl og benzioksazolazabicyklisk derivater
DE60220654D1 (de) Musterungsmethode
ATE502118T1 (de) Amplifizierungsverfahren
DE60303409D1 (de) Aufzeichnungsgerät
DE60320339D1 (de) Aufzeichnungsgerät
DK1572950T3 (da) Enkeltdomæne TDF-relaterede forbindelser og analoger deraf
DE60303241D1 (de) Aufzeichnungsgerät
DE60333210D1 (de) Desinfektionsmethode
DE60219401D1 (de) Aufzeichnungsgerät
NO20042810L (no) Venflaxine-hydroklorid-monohydrat og fremgangsmater for fremstilling derav
DE60331835D1 (de) In-line rollschuh rahmen
DE60204089D1 (de) Bilderzeugungsverfahren
DE60235514D1 (de) Aufzeichnungsgerät
EP1626053A4 (en) ALPHA-SELECTIVE GLYCOSYLATION PROCESS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application